IMA vs KEY
ImageneBio, Inc. (IMA) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
IMA currently screens at market cap $64.7M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the IMA and KEY stock pages for the full models.
Not investment advice.